Who
Daniel D. Long
SVP, Drug Discovery
Company insider
Files Form 4 as: SVP, Drug Discovery, Septerna.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $1.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Aug 2025
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $9,1993,333 at $2.76 | filing |
| 1 Sep 2026filed 3 Sep 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $126K3,333 at $37.83 | filing |
| 1 Sep 2026filed 3 Sep 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,333 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,333 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $9,1993,333 at $2.76 | filing |
| 1 Sep 2026filed 3 Sep 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $126K3,333 at $37.83 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $5,0121,816 at $2.76 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $4,1901,518 at $2.76 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $34K1,000 at $33.98 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,816 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,518 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $81K2,334 at $34.68 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,816 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,518 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $5,0121,816 at $2.76 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $4,1901,518 at $2.76 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $34K1,000 at $33.98 | filing |
| 3 Aug 2026filed 5 Aug 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $81K2,334 at $34.68 | filing |
| 1 Jul 2026filed 2 Jul 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Code M | $9,1993,333 at $2.76 | filing |
| 1 Jul 2026filed 2 Jul 2026 | SEPN SepternaBiotechnology | SEC FORM 4 Sold | $72K2,100 at $34.10 | filing |
News
Comparing Septerna (NASDAQ:SEPN) and INmune Bio (NASDAQ:INMB)SEPN · themarketsdaily.com · 24 Oct 2026Septerna (NASDAQ:SEPN) COO Sells $149,640.00 in StockSEPN · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Daniel D. Long; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.